Home
Stock Market News
Market Sentiment
Trending Industries
Blogs
Contact us
Insmed (INSM) Rose Due to Positive Trial Results
Carillon Tower Advisers released its Q2 2024 investor letter highlighting the Carillon Eagle Small Cap Growth Fund's performance. Small-cap stocks ended the quarter negatively.